Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Approves First Cancer Drug Under New Real Time Review Program
FDA Approves First Cancer Drug Under New Real Time Review Program
FDA Approves First Cancer Drug Under New Real Time Review Program
Submitted by
admin
on July 18, 2018 - 1:39pm
Source:
CP Wire
News Tags:
FDA
Novartis
Kisqali
breast cancer
Scott Gottlieb
Real Time Oncology Review
Headline:
FDA Approves First Cancer Drug Under New Real Time Review Program
snippet:
Kisqali approved under Real Time Oncology Review Program
One of two new programs intended to make the development of cancer drugs more effecient
Approval came less than one month after submission
Do Not Allow Advertisers to Use My Personal information
